1Welty-Wolf KE, Carraway MS, Miller DL, et al. Coagulation blockade prevents sepsis-induced respiratory and renal failure in baboons[J]. Am J Respir Crit Care Med,2001,164:1988-1996.
2Carraway MS, Welty-Wolf KE, Miller DL, et al. Blockade of tissue factor: treatment of organ injury in established sepsis [J]. Am J Respir Crit Care Med, 2003, 167:1200-1209.
3Gando S, Nanzaki S, Morimoto Y, et al. Systemic activation of tissuefactor dependent coagulatiou pathway in evolving acute respiratory distress syndrome in patients with trauma and sepsis[J]. J Trauma, 1999,47:719-723.
4Gunther A, Mosavi P, Heinemann S, et al. Alveolar fibrin formation caused by enhanced procoagulant and depressde fibrinolytic capacities in severe pneumonia[J]. Am J Respir Crit Care Med, 2000,161:454-462.
5Abraham E. Coagulation abnormalities in acute lung injury and sepsis [J].Am J Respir Cell Mol Biol,2000,22:401-404.
6Ge M, Ryan TJ, Lum H, et al. Fibrinogen degradation product fragment D increases endothelial monolayer permeability[J]. Am J Physiol, 1991,261:L283-289.
7VHermans PW, Hibberd ML, Booy R, et al. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal research group[J] .Lancet, 1999,354: 550-560.
8Lane DA, Grant PJ. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease[J] .Blood,2000,95:1517-1529.
9Fourrier F, Chopin C, Goudemand J, et al. Septic shock, multiple organ failure and disseminated intravascular coagulation: compared patterns of antithrombin Ⅲ, protein C and protein S deficiencies[J]. Chest, 1992,101:816-823.
10Baido F, Caimi TM, de Cataldo F, et al. Antithrombin Ⅲ ( AT Ⅲ )replacement therapy in patients with sepsis and/or postsurgical complications: a controlled, double - blind, randomized, multicenter study [J]. Intensive Care Med, 1998,24:336-342.
